Progeny bioVentures Limited Company Profile

15:04 EDT 19th September 2017 | BioPortfolio

Progeny bioVentures is a subsidiary of ANGLE Technology Ltd with the remit to establish new companies from the UK bioscience base. Progeny appraises new company opportunities, develops business plans and secures funding from venture capital and other sources. Progeny's financial return depends entirely on the success of the companies it establishes. Equity stakes are negotiated as appropriate with the scientific innovators, the technology source organisation and funding sources.

Progeny provides access to a seasoned management team with in-depth experience of company start-ups and biotech product development. As the new Company develops, Progeny is able to access a fulltime management team through ANGLE Technology.

Progeny has been granted an award under the Department of Trade and Industry’s Biotechnology Mentoring and Incubation (BMI) Challenge in collaboration with University of Bristol and supported by the Universities of Southampton and Edinburgh and the Rowett Research Institute. However, Progeny extends to all UK universities, research institutes and technology source organisations including major corporates.

The Progeny process involves:

·Appraisal and protection of intellectual property and freedom-to-operate.

·Market research, including analysis of competitors market entry barriers

·Business planning

·Company formation

·Raising finance from venture capital and non-dilutive sources.

·Commercial and general management

·Early stage partnering, including licence negotiation and technology acquisition.

·Securing permanent, experienced management to take the Company through to product launch and beyond.

For further information please contact Bill Mullen or Ioan Cleaton Jones on 01483 295830 or at


Surrey Technology CentreSurrey Research Park
United Kingdom


Phone: 44 01483 295830
Fax: 44 01483 295836

News Articles [30 Associated News Articles listed on BioPortfolio]

Rigaku Analytical Devices to Present Feature Enhancements to Handheld Raman Analyzer at IAFC Hazmat Response Teams Conference

New capabilities of Rigaku Progeny ResQ 1064nm handheld Raman will streamline user’s incident response Baltimore, Maryland (PRWEB) June 16, 2017 Rigaku Corporation is pleased to announce that Rigak...

Rigaku Analytical Devices Participates in Podcast; Now Available for Download on Demand

Rigaku Progeny ResQ handheld Raman analyzer is featured in a podcast hosted by ‘The Hazmat Guys.’ Wilmington, MA (PRWEB) May 31, 2017 Rigaku Corporation is pleased to announce that Rigaku Analyti...

WuXi Healthcare Ventures, Frontline BioVentures Merge to Form $800 Million Powerhouse Biotech Fund

  Life Sciences Jobs   ...

WuXi Healthcare Ventures, Frontline BioVentures Merger to Form $800 Million Powerhouse Biotech Fund

  Life Sciences Jobs   ...

China merger lets loose $800 million VC behemoth

Chinese healthcare investment firms Frontline BioVentures and WuXi Healthcare Ventures are to merge,…

WuXi Healthcare Ventures and Frontline BioVentures Join Forces to Form 6 Dimensions Capital, a Leading China and U.S. Focused Investment Group Specializing in Healthcare and Life Sciences

  Life Sciences Jobs   ...

Animal Study Finds High-Fat Diet in Pregnancy Increases Breast Cancer Risk Over Generations

“It is believed that environmental and life-style factors, such as diet, plays a critical role in increasing human breast cancer risk, and so we use animal models to reveal the biological mechan...

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

PubMed Articles [89 Associated PubMed Articles listed on BioPortfolio]

Insulin-like signalling to the maternal germline controls progeny response to osmotic stress.

In 1893 August Weismann proposed that information about the environment could not pass from somatic cells to germ cells, a hypothesis now known as the Weismann barrier. However, recent studies have in...

Aubergine Controls Germline Stem Cell Self-Renewal and Progeny Differentiation via Distinct Mechanisms.

Piwi family protein Aubergine (Aub) maintains genome integrity in late germ cells of the Drosophila ovary through Piwi-associated RNA-mediated repression of transposon activities. Although it is highl...

Impact of Co-Culturing with Fractionated Carbon-Ion-Irradiated Cancer Cells on Bystander Normal Cells and Their Progeny.

The purpose of this study was to compare the biological effects of fractionated doses versus a single dose of high-LET carbon ions in bystander normal cells, and determine the effect on their progeny ...

Integrated analysis of mRNA and miRNA expression profiling in rice backcrossed progenies (BC2F12) with different plant height.

Inter-specific hybridization and backcrossing commonly occur in plants. The use of progeny generated from inter-specific hybridization and backcrossing has been developed as a novel model system to ex...

Evaluation of the separation and purification of (227)Th from its decay progeny by anion exchange and extraction chromatography.

Thorium-227 is currently undergoing evaluation as a potential radionuclide for targeted cancer therapy, and as such a high chemical purity of the material is required. To establish a reliable procedur...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Stem Cells and Tibial Fractures

The aim of this trial is to determine the safety and tolerability of expanded autologous progeny of an adult CD34+ (haemopoietic) stem cell subset when infused directly into the tibial art...

Companies [104 Associated Companies listed on BioPortfolio]

Progeny bioVentures Limited

Progeny bioVentures is a subsidiary of ANGLE Technology Ltd with the remit to establish new companies from the UK bioscience base. Progeny appraises new company opportunities, develops business plans...

Frontline BioVentures

Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life ...

BioVentures, Inc.

BioVentures, Inc. is committed to the highest levels of scholarship through the submission of original research to peer reviewed publications and presentation of our data at scientific conferences. In...

Progeny Genetics LLC

Alpine BioVentures

Alpine BioVentures is a venture capital firm committed to investing in and building revolutionary healthcare companies. It brings a unique perspective to identify game-changing sc...

More Information about "Progeny bioVentures Limited" on BioPortfolio

We have published hundreds of Progeny bioVentures Limited news stories on BioPortfolio along with dozens of Progeny bioVentures Limited Clinical Trials and PubMed Articles about Progeny bioVentures Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Progeny bioVentures Limited Companies in our database. You can also find out about relevant Progeny bioVentures Limited Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record